Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about IONS
Recent news which mentions IONS
< Previous
1
2
3
4
5
Next >
Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges
September 27, 2023
Tickers
ALNY
AZN
IONS
NVS
Tags
Market News
Benzinga
Contracts
From
Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
September 27, 2023
Tickers
IONS
Tags
Benzinga
BZI/AAR
IONS
From
Benzinga
Why Ionis Pharmaceuticals Stock Popped Today
September 26, 2023
Tickers
IONS
Tags
Market News
Benzinga
why it's moving
From
Benzinga
Ionis Pharmaceuticals' Rare Metabolic Disorder Candidate Poised To Become New Standard Treatment, Study Shows Encouraging Action
September 26, 2023
Tickers
IONS
Tags
Benzinga
Market News
Health Care
From
Benzinga
The 7 Most Hated Stocks by Institutional Traders
September 20, 2023
Tickers
GS
IONS
LLY
PDD
Tags
TOST
PTON
NASDAQ:PTON,NYSE:TOST,NASDAQ:IONS,NASDAQ:TMUS,NASDAQ:PDD,NYSE:GS,NYSE:LLY
From
InvestorPlace
Hypertension Impacts 1.2B People - Alnylam's Gene Silencing Drug Candidate Hits the Mark in Phase 2 Study, Offering Hope
September 07, 2023
Tickers
ALNY
IONS
RHHBF
RHHBY
Tags
Expert Ideas
Analyst Color
RHHVF
From
Benzinga
Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports
August 07, 2023
Tickers
ACCD
ARKG
ARKK
ARKW
Tags
QSI
News
RXRX
From
Benzinga
Analyst Upgrades Ionis Pharmaceuticals To Buy Amid Key Pipeline Developments: Eplontersen And Donidalorsen Show Promising Outlook
July 31, 2023
Tickers
ALNY
AZN
IONS
Tags
Analyst Color
Expert Ideas
Markets
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
July 31, 2023
Tickers
A
ABR
ADBE
AIV
Tags
ABR
NYXH
CPRI
From
Benzinga
Apple To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Monday
July 31, 2023
Tickers
AAPL
ADBE
BAX
CMCSA
Tags
Price Target
ADBE
PG
From
Benzinga
Biogen Reports New Spinraza Data In Atrophy Patients After Incomplete Response To Novartis' Treatment
July 03, 2023
Tickers
BIIB
IONS
NVS
Tags
Benzinga
Market News
Analyst Ratings
From
Benzinga
Hereditary Angioedema Update Solidifies Intellia's Cell Therapy's Competitive Efficacy Profile: Analyst
June 12, 2023
Tickers
IONS
NTLA
Tags
News
Briefs
IONS
From
Benzinga
Analyst Creates Bullish Pitch On Ionis Pharmaceuticals Citing 'Strategic Pivot Underway'
June 07, 2023
Tickers
AZN
IONS
Tags
Health Care
AZN
Biotech
From
Benzinga
Why Ionis Pharmaceutical Shares Are Trading Lower Wednesday
June 07, 2023
Tickers
IONS
Tags
IONS
News
why it's moving
From
Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
June 07, 2023
Tickers
IONS
Tags
BZI/AAR
IONS
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
May 04, 2023
Tickers
ABSI
BLDR
BLKB
CERE
Tags
SPR
BLKB
ISEE
From
Benzinga
Recap: Ionis Pharmaceuticals Q1 Earnings
May 03, 2023
Tickers
IONS
Tags
Market News
Earnings
BZI/Recaps
From
Benzinga
Ionis Pharmaceuticals's Earnings Outlook
May 02, 2023
Tickers
IONS
Tags
IONS
Benzinga
Earnings
From
Benzinga
Biogen's Amyotrophic Lateral Sclerosis Drug Scores Conditional Approval From FDA
April 26, 2023
Tickers
BIIB
IONS
Tags
Market News
Benzinga
FDA
From
Benzinga
FDA grants accelerated approval to Biogen treatment for rare form of ALS
April 25, 2023
Tickers
BIIB
IONS
Tags
IONS
BIIB
From
MarketWatch
What's Going On With Biogen Stock Tuesday?
April 25, 2023
Tickers
BIIB
IONS
Tags
Market News
Benzinga
FDA
From
Benzinga
Biogen Announces Additional Cost Cutting Initiatives, Chops Certain Stroke, Gene Therapy Programs
April 25, 2023
Tickers
BIIB
IONS
Tags
General
IONS
Briefs
From
Benzinga
3 Biotech Stocks to Sell Before They’re 6 Feet Under
April 24, 2023
Tickers
ACRS
AMRS
IONS
Tags
Market News
ACRS
AMRS
From
InvestorPlace
AstraZeneca, Ionis Unveil Complete Phase 3 Data For ATTR Candidate, Says Drug Halts Disease Progression
April 24, 2023
Tickers
AZN
AZNCF
IONS
Tags
IONS
General
Briefs
From
Benzinga
Could This Rare-Disease Drug Candidate Become a Blockbuster?
April 19, 2023
Tickers
AZN
IONS
Tags
IONS
Recent Press Releases
Market News
From
Motley Fool
Analyst Upgrades Arrowhead Pharma Citing 'Attractive Risk/Reward'
April 12, 2023
Tickers
ALNY
ARWR
IONS
MRNA
Tags
General
Upgrades
ALNY
From
Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
April 11, 2023
Tickers
IONS
Tags
Benzinga
IONS
BZI/AAR
From
Benzinga
AstraZeneca-Ionis Partnered Rare Disease Drug Data Shows Sustained Benefit; Drug Under FDA Review
March 27, 2023
Tickers
AZN
AZNCF
BXRX
IONS
Tags
Health Care
Biotech
AZN
From
Benzinga
FDA Adcomm Says Benefit-Risk Profile Favor Biogen's Tofersen For Inherited Neuro Disorder
March 23, 2023
Tickers
BIIB
IONS
Tags
FDA
Benzinga
Market News
From
Benzinga
Analyst Ratings for Ionis Pharmaceuticals
March 21, 2023
Tickers
IONS
Tags
IONS
BZI/AAR
Benzinga
From
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.